Free Trial

Teva Pharmaceutical Industries (TEVA) SEC Filings & 10K Form

Teva Pharmaceutical Industries logo
$16.76 0.00 (0.00%)
As of 06/30/2025 03:58 PM Eastern

Recent Teva Pharmaceutical Industries SEC Filings

DateFilerForm TypeView
06/09/2025
3:15 PM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:18 PM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:20 PM
Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:22 PM
Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:25 PM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:52 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
3:16 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
4:13 PM
Teva Pharmaceutical Industries (Subject)
Form FWP
05/19/2025
5:50 AM
Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Finance Netherlands IV B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
Form 424B5
05/08/2025
1:34 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
3:06 PM
Teva Pharmaceutical Industries (Filer)
Form DEF 14A
04/07/2025
3:01 PM
Lippman Evan (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2025
3:22 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:25 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:29 PM
Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:13 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:16 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:06 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:08 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:11 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:13 PM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:29 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:08 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:14 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
03/04/2025
5:57 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:02 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:30 PM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:37 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:44 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:07 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:59 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:14 PM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
10:52 AM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
11:38 AM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
7:06 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
3:06 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:03 PM
BRIDGER MANAGEMENT, LLC (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:04 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
11/20/2024
10:39 AM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
9:34 AM
FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G
11/06/2024
3:06 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
6:40 AM
Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:06 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
08/14/2024
5:24 AM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
08/12/2024
3:09 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
6:32 AM
Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:35 AM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:30 AM
Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
3:06 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:TEVA) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners